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Cytomegalovirus (CMV) is an opportunistic virus
severely infecting immunocompromised individuals.
In mice, endosomal Toll-like receptor 9 (TLR9)
and downstream myeloid differentiation factor 88
(MyD88) are central to activating innate immune re-
sponses againstmouseCMV (MCMV). In this respect,
the cell-specific contribution of these pathways in
initiating anti-MCMV immunity remainsunclear.Using
transgenic mice, we demonstrate that TLR9/MyD88
signaling selectively in CD11c+ dendritic cells (DCs)
strongly enhances MCMV clearance by boosting nat-
ural killer (NK) cell CD69 expression and IFN-g pro-
duction. In addition, we show that in the absence of
plasmacytoid DCs (pDCs), conventional DCs (cDCs)
promote robust NK cell effector function and MCMV
clearance in a TLR9/MyD88-dependent manner.
Simultaneously, cDC-derived IL-15 regulates NK cell
degranulation by TLR9/MyD88-independent mecha-
nisms. Overall, we compartmentalize the cellular
contribution of TLR9 and MyD88 signaling in individ-
ual DC subsets and evaluate themechanismbywhich
cDCs control MCMV immunity.
INTRODUCTION
Cytomegalovirus (CMV) exhibits a broad tropism in humans,
leading to a diverse range of infection-associated pathologiesCell Re
This is an open access article under the CC BY-N(Tabeta et al., 2004). In immunocompromised people, such as
AIDS and transplant patients, as well as in unborn individuals
infected during gestation, CMV is highly pathogenic. Despite
numerous efforts, no effective vaccine exists against CMV
(Ahmed, 2011). Furthermore, current anti-viral therapy is associ-
ated with numerous drawbacks, such as poor bioavailability,
development of anti-viral drug resistance, and associated cyto-
toxicities (Plotkin, 2015). This warrants for an urgent requirement
to design alternative approaches to enhance immune responses
against CMV.
Mouse CMV (MCMV) is a natural pathogen in mice. The
MCMV model of infection recapitulates the key immunological
hallmarks of human CMV (HCMV) infection and is broadly
used as a tool for studying immune responses against CMV.
MCMV exhibits a broad cellular tropism (Krmpotic et al., 2003)
with defined kinetics. After systemic infection, the spleen serves
as an initial reservoir for MCMV replication, promoting the
dissemination of virus to other organs (Alexandre et al., 2014).
Viral replication commences in non-hematopoietic stromal cells
6–8 hr post-infection (p.i.), and virus disseminates to splenic red
pulp cells by 17 hr before reaching the white pulp cells between
day 1.5 and day 2 p.i. (Hsu et al., 2009), when conventional den-
dritic cells (cDCs) and plasmacytoid dendritic cells (pDCs) pro-
duce cytokines including type I interferon (IFN-I) and interleukin
(IL) 12 (Dalod et al., 2002; Zucchini et al., 2008a). Dendritic cell
(DC)-derived cytokines promote host survival by facilitating nat-
ural killer (NK) cell proliferation and effector function (Dalod
et al., 2003; Nguyen et al., 2002) and blocking viral replication
(Orange and Biron, 1996a). Specifically, IL-12 has been shown
to induce NK cell-mediated interferon (IFN)-g production, while
IFN-I promotes IL-15-induced NK cell survival and cytotoxicports 17, 1113–1127, October 18, 2016 ª 2016 The Authors. 1113
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. TLR9 and MyD88 Signaling in CD11c+ Cells Controls MCMV Infection In Vivo
(A and B) Lethally irradiated recipient CD45.1 WT mice were reconstituted with donor CD45.2 WT, TLR9/, or MyD88OFF BM or irradiated recipient CD45.2 WT,
TLR9/, or MyD88OFF mice were reconstituted withWT BM and then infected i.p. with 53 105 PFUs of MCMV. Viral load in the spleen (A) and in the liver (B) were
evaluated at day 1.5 p.i.
(legend continued on next page)
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capacity (Baranek et al., 2012; Nguyen et al., 2002; Orange and
Biron, 1996a, 1996b). Simultaneously, MCMV-induced IL-18
enhances secretion of IFN-g by NK cells (Pien et al., 2000), as
well as Ly49H+ NK cell expansion in the spleen (Andrews
et al., 2003); however, it is not critical for NK cell-mediated pro-
tection against MCMV (Cocita et al., 2015), because IL-18/
mice survive the infection (Pien et al., 2000). Despite the
important role of pDC-derived cytokines, ablation of pDCs by
anti-PDCA-1/Bst2/120G8 antibody (Cocita et al., 2015) or by
diphtheria toxin (DT) injection in blood dendritic cell antigen
2 (BDCA2)-diphtheria toxin receptor (DTR) transgenic mice
(Swiecki et al., 2010) minimally influences NK cell activation.
These findings suggest that NK cell function during MCMV
infection is not governed solely by signals derived from pDCs
but may also depend on immunological cues from other cell
types.
Pro-inflammatory cytokine production is triggered by direct
sensing of MCMV, which occurs primarily through endosomal
Toll-like receptor (TLR) 9, along with a partial redundancy for
TLR7 (Zucchini et al., 2008b). Both TLR9 and TLR7 signal via
the downstream adaptor molecule myeloid differentiation factor
88 (MyD88) (Delale et al., 2005; Krug et al., 2004; Tabeta et al.,
2004). Complete loss of TLR9 or MyD88 in mice severely com-
promises MCMV clearance from infected organs (Krug et al.,
2004; Zucchini et al., 2008b). This impaired resistance to
MCMV in TLR9 andMyD88 knockout (KO) (/) mice is primarily
attributed to reduced IFN-I production and NK cell activation
(Krug et al., 2004; Zucchini et al., 2008b). The induction of
IFN-I after systemic MCMV infection has been shown to be
biphasic (Schneider et al., 2008). The first short-lived peak at
8 hr p.i. is mainly stromal cell derived, while the second, more
sustained peak from day 1.5 p.i. (Schneider et al., 2008) is pDC
derived (Dalod et al., 2002). It remains unclear whether stromal
cells, in addition to DCs, contribute to protection against
MCMV at the early phase of infection. In this regard, the cell-spe-
cific requirement of TLR9 and MyD88 signaling in the immune
control of MCMV infection warrants a rigorous investigation.
To address these questions, we generated bone marrow (BM)
chimeric mice lacking TLR9 or MyD88 in hematopoietic cells or
non-hematopoietic cells, as well as transgenic mice with selec-
tive deletion of TLR9 or reactivation of MyD88 in CD11c+ cells.
In addition, using a mouse model in which CD11c+ cells can be
selectively depleted by administration of DT, we compare the
contribution of TLR9 and MyD88 sensing by cDCs versus
pDCs in controlling MCMV. By generating genetically engi-
neered mice to target DC subsets in vivo after MCMV infection,
we show that the loss of pDC-derived signals can be compen-
sated by TLR9 and MyD88 signaling in cDCs, promoting
NK cell activation, cytokine production, and viral clearance.
Overall, we demonstrate a previously less understood function(C and D) WT (C57BL/6), TLR9/, ItgaxCre, and ItgaxCre+/TLR9fl/fl and litterma
load was determined in the spleen (C) and liver (D) at day 1.5 p.i. (C) and (D) are
(E–I) WT, TLR9/, DC-MyD88ON, pDC-MyD88ON, andMyD88OFF were infected i.p
an overlay of viral bioluminescence, with mouse computer tomography scan show
ItgaxCre+/TLR9fl/fl mice (E) and WT, MyD88OFF, DC-MyD88ON, and pDC-MyD88
and days 3, 6, and 8 p.i. (G). Data are from one of three individual experiments w
NS, not significant; ***p < 0.001, **p < 0.01, *p < 0.05; Kruskal-Wallis test.of cDCs in shaping immune responses to MCMV by using
TLR9/MyD88-dependent mechanisms.
RESULTS
TLR9 and MyD88 Function in CD11c+ Cells Controls
MCMV Clearance
To carefully compartmentalize the contribution of TLR9 and
MyD88 signaling in hematopoietic versus non-hematopoietic
cells during MCMV infection, we generated wild-type (WT),
TLR9/, and MyD88OFF (harboring a floxed transcriptional
termination element between exons 1 and 2 of the Myd88
gene) (Gais et al., 2012) BM chimeric mice. These mice lack
either TLR9 or MyD88 in hematopoietic, non-hematopoietic, or
both compartments. Chimeric mice were infected with MCMV,
and spleen and liver were harvested at day 1.5 p.i. to determine
the viral load. Mice lacking TLR9 or MyD88 only in the hemato-
poietic compartment exhibited significantly higher viral load in
the spleen than WT chimeric mice (Figure 1A). In contrast, viral
load in the liver was MyD88 dependent but TLR9 independent
(Figure 1B). In addition, mice that lack TLR9 or MyD88 in non-he-
matopoietic cells alone have comparable viral titers to WT
chimeric mice (Figures 1A and 1B), excluding a contribution of
the TLR9/MyD88 pathways in this compartment. Altogether,
our data clearly indicate that TLR9/MyD88 signaling in hemato-
poietic cells is sufficient to control MCMV in the spleen at day
1.5 p.i.
Next, we addressed the cell-specific role of TLR9 in DCs and
its consequent impact on MCMV clearance by generating useful
genetically engineered loxP-flanked TLR9 (TLR9 flox, or TLR9fl/fl)
mice (Figure S1A), in which exon 2 (carrying the main coding
sequence) of the Tlr9 gene is flanked by loxP sites. TLR9fl/fl
mice were crossed to CD11c Cre mice (expressing Cre recombi-
nase under the control of the Itgax promoter) (Caton et al., 2007),
thereby allowing selective deletion of TLR9 in CD11c+ cells.
These mice are further denoted as ItgaxCre+/TLR9fl/fl. Cre
expression in ItgaxCre mice was demonstrated to occur pre-
dominantly in DCs (95% of CD11chigh cDCs and 50%–80% of
pDCs), with a low amount of recombination in T lymphocytes
(<10%), NK cells (12%), and myeloid cells (<1%) (Caton et al.,
2007). Similarly, in our conditional KOmice, in which Cre expres-
sion is driven by the same CD11c promoter, TLR9 is efficiently
deleted in both cDC and pDC subsets (Figure S1B), resulting in
the loss of DC-specific TLR9 function upon stimulation (Figures
S1C and S1D). Infection of these mice with MCMV indicates
that by day 1.5 p.i., the viral load in the spleen was comparable
to that in TLR9/ mice and significantly higher than that in WT
controls (Figure 1C), whereas titers in the liver were similar in
all groups (Figure 1D). This finding is in concordance with the re-
sults displayed in Figure 1B, demonstrating that the anti-viralte controls ItgaxCre/TLR9fl/fl were infected with 5 3 105 PFUs MCMV. Viral
pooled data from three experiments with n = 3–4 mice per group.
. with MCMV luciferase at 53 105 PFUs. (E and H) Intravital imaging displaying
ingMCMV viral load in the abdominal cavity at day 1.5 p.i. of WT, TLR9/, and
ON mice (H). Photon flux (p/s) quantification is shown at day 1.5 p.i. (F, G, and I)
ith similar results. n = 3–4 mice/group/experiment.
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Figure 2. NK Cell Activation and Function Are Compromised in Mice Lacking TLR9 and MyD88 Signaling in CD11c+ Cells
(A–H) TLR9/, ItgaxCre+/TLR9fl/fl, and ItgaxCre/TLR9fl/fl mice (A, C, E, and G) and WT, MyD88OFF, DC-MyD88ON, and pDC-MyD88ON mice (B, D, F, and H)
were infected with 53 105 PFUs of MCMV or PBS treated (Mock), and spleens were harvested at day 1.5 p.i. (A and B) Total number of NK cells (NK1.1+CD3).
(legend continued on next page)
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response in the liver at day 1.5 p.i. is TLR9 independent. In
contrast, the viral load in LysMCre+/TLR9fl/fl mice, in which
TLR9 deletion occurs in LysM+ cells (Clausen et al., 1999) such
as macrophages and neutrophils, was comparable to that in
WT mice (Figures S2A and S2B). We then examined MCMV
load at day 1.5 p.i. using a luciferase-expressing strain of
MCMV and intravital imaging. The strength of the bioluminescent
signal, which correlates to viral burden, was significantly higher
in the peritoneum of mice lacking TLR9 (TLR9/) or Itgax-
Cre+/TLR9fl/fl mice than in WT controls (Figures 1E and 1F).
The overall bioluminescent signal between TLR9/ and Itgax-
Cre+/TLR9fl/fl mice was comparable with minor variation in virus
distribution across the peritoneum (Figure S2C). Furthermore,
luminescence remained high until day 3 p.i. and decreased by
day 8 p.i., when infection was cleared in all mice (Figure 1G).
To investigate the importance of MyD88 in DCs, we next
crossed ItgaxCre mice (Caton et al., 2007) or pDCre mice (Puttur
et al., 2013) withMyD88OFFmice. Themice generated from these
crossings, here termed DC-MyD88ON and pDC-MyD88ON, reac-
tivate Myd88 gene expression in CD11c+ cells or in Siglec-H+
cells, respectively, and have been carefully characterized in
our previous work (Arnold-Schrauf et al., 2014; Berod et al.,
2014; Dudek et al., 2016). Reactivation of MyD88 in CD11c+
cells (DC-MyD88ON) significantly improved clearance of MCMV
compared to mice that reactivated MyD88 only in a representa-
tive fraction of pDCs (pDC-MyD88ON) or mice that lackedMyD88
in all cells (MyD88OFF) (Figures 1H and 1I). Overall, our findings
suggest that TLR9 and MyD88 signaling in CD11c+ cells is
mandatory to control splenic MCMV infection at day 1.5 p.i.
NK Cell Activation and IFN-g Production Are
Compromised in Mice Lacking TLR9 and MyD88
Signaling in CD11c+ Cells
NKcells are central players in promoting host immune responses
against MCMV by rapidly secreting cytokines and releasing
cytotoxic granules to kill infected cells (Lodoen and Lanier,
2006). MCMV is sensed predominantly by TLR9, and mice defi-
cient in TLR9 show significantly reduced NK cell CD69 expres-
sion and NK cell IFN-g production after 2 days of infection
(Krug et al., 2004). Given that ItgaxCre+/TLR9fl/fl mice and
DC-MyD88ON mice showed complementary effects in MCMV
clearance, we next evaluated NK cell responses in these mice.
NK T cells were excluded by co-staining with anti-CD3 antibody
(Figure S3). Following systemicMCMV infection, splenic NK cells
rapidly undergo cytokine-driven proliferation and contraction
due to cellular apoptosis (Dokun et al., 2001; Robbins et al.,
2004; Schlub et al., 2011; Stacey et al., 2011). Similarly, in our
infection model, WT mice showed a significant reduction in the
total number of NK cells present in the spleen at day 1.5 p.i.
compared to the mock-infected controls (Figures 2A and 2B).
This contraction in the number of NK cells was less pronounced
in TLR9/, ItgaxCre+/TLR9fl/fl, andMyD88OFF mice (Figures 2A(C and D)MFI of CD69 expression on splenic NK cells. (E–H) Splenocytes were inc
(G and H) of IFN-g+ NK cells are depicted for the individual mice.
(I) Representative flow cytometry plots of graphs shown in (E) and (F).
Data are pooled from one of two individual experiments with similar results. n = 3
ANOVA with Tukey post test.and 2B). In addition, during the early phase of infection, reactiva-
tion of MyD88 in CD11c+ cells led to a similar reduction in
the number of NK cells compared to WT mice, whereas pDC-
MyD88ON mice failed to induce NK cell contraction (Figure 2B).
Besides, complete or CD11c-specific deletion of TLR9/MyD88
signaling strongly reduced the mean fluorescence intensity
(MFI) of CD69 on NK cells (Figures 2C and 2D) and the frequency
and number of IFN-g+ NK cells (Figures 2E, 2G, and 2I). Comple-
mentary effects were observed when MyD88 was reactivated in
CD11c+ cells, increasing expression of CD69 on NK cells (Fig-
ure 2D), as well as the frequency (Figures 2F and 2I) and number
(Figure 2H) of IFN-g+ NK cells. Reactivation of MyD88 in pDCs
was not sufficient to restore CD69 expression and IFN-g to WT
levels. Our results show that NK cell activation and IFN-g pro-
duction are regulated by TLR9/MyD88-derived signals from
CD11c+ cells, which are mainly DCs.
After the initial contraction phase, NK cells proliferate and
expand between day 2 and day 7 p.i. (Schlub et al., 2011). This
NK cell expansion is mostly restricted to Ly49H+ NK cells recog-
nizing m157 (Min-Oo and Lanier, 2014) and is phenotypically
characterized by KLRG1 expression (Robbins et al., 2004). We
evaluated the frequencies of KLRG1+Ly49H+ versus KLRG1+
Ly49H NK cells at day 8 p.i. and observed that infection
increased the frequencies of KLRG1+ expressing Ly49H+ NK
cells to a similar extent in WT and ItgaxCre+/TLR9fl/fl mice
compared to mock mice (Figure S4). This suggests that TLR9
function in CD11c+ cells may only influence the early NK cell
response.
NK Cell Cytotoxicity Is Independent of TLR9 and MyD88
Function
Because CD11c-driven TLR9 and MyD88 signaling strongly
contributed to NK cell CD69 expression and IFN-g production,
we next evaluated the cytotoxic capacity of NK cells. Surpris-
ingly, compared to WT, the ability of NK cells to kill YAC-1 target
cells at day 1.5 p.i. remained unchanged in the absence of TLR9
or MyD88 (Figure 3A). NK cell cytotoxicity has been shown to
be promoted by IFN-I (Andoniou et al., 2005; Nguyen et al.,
2002). However, although a role for IFN-a in NK cell cytotoxic ac-
tivity during MCMV infection was previously ruled out (Orange
and Biron, 1996b), the contribution of IFN-b remains unclear.
For example, in IRF7/ mice that lack IFN-a, normal NK cell
degranulation has been related to the presence of IFN-b (Stein-
berg et al., 2009). To test this hypothesis, IRF7/ mice (Honda
et al., 2005) were bred to an IFN-b reporter mouse (Lienenklaus
et al., 2009) (referred to as IFN-bWT/D in our study). Mice bred het-
erozygously for the targeted Dbluc mutation (IRF7/IFN-bWT/D)
have normal IFN-b production due to the presence of a functional
WT allele, whereas homozygous (IRF7/IFN-bD/D) mice lack
IFN-b after systemic MCMV infection (Figure S5). MCMV-
infected IRF7/ mice show comparable levels of NK cell cyto-
toxicity (Figure 3B) and NK cell degranulation, as evidenced byubated with IL-2 (2 hr) and brefeldin A (4 hr). Frequencies (E and F) and numbers
–5 mice/group; NS, not significant; ***p < 0.001, **p < 0.01, *p < 0.05; one-way
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Figure 3. NK Cell Cytotoxicity Is Independent of TLR9 and MyD88 Signaling
(A) TLR9/, ItgaxCre+/TLR9fl/fl, ItgaxCre/TLR9fl/fl, MyD88OFF, DC-MyD88ON, and pDC-MyD88ON mice were infected with 5 3 105 PFUs of MCMV. Spleens
were harvested at day 1.5 p.i., and NK cells were sorted for chromium release assays.
(B andC) To exclude the contribution of IFN-b in NK cell cytotoxicity, splenic NK cells were sorted from IRF7/IFN-bD/Dmice for chromium release assays (B) and
CD107a degranulation assays (C).
(D) IFN-a levels at day 1.5 p.i. in sera of IRF7/IFN-bD/D mice compared to infected control IFN-bWT/D mice.
(E) NK cell degranulation in WT control and IFNAR-1/ mice.
Data are from one of two individual experiments with similar results. n = 3–5 mice/group ± SD; NS, not significant; ***p < 0.001, **p < 0.01, *p < 0.05; one-way
ANOVA with Tukey post test.CD107a expression (Figure 3C), like IRF7/IFN-bWT/D or
IFN-bWT/D mice. No IFN-a can be detected in the serum
of IRF7/IFN-bD/D mice, excluding a contribution of residual
IFN-a to NK cell-mediated cytotoxicity (Figure 3D). Finally, we
ruled out the involvement of IFN-I in NK cell degranulation by us-
ing IFNAR-1/mice, because we observed comparable NK cell
degranulation between MCMV-infected IFNAR-1/ and WT
mice (Figure 3E). Overall, our results show that NK cell degranu-1118 Cell Reports 17, 1113–1127, October 18, 2016lation and cytotoxic capacity upon MCMV infection are TLR9/
MyD88 and IFN-I independent.
TLR9/MyD88 Signaling in CD11c+ Cells Regulates the
Anti-viral Cytokine Response to MCMV
Pro-inflammatory DC-derived cytokines, specifically IFN-I and
IL-12, promote NK cell activation and cytokine production after
MCMV infection (Baranek et al., 2012; Orange and Biron,
Figure 4. TLR9/MyD88 in DCs Regulates the Pro-inflammatory Cytokine Response against MCMV
(A–F) WT, TLR9/, ItgaxCre+/TLR9fl/fl, MyD88OFF, DC-MyD88ON, and pDC-MyD88ON mice were infected with 5 3 105 PFUs of MCMV. IFN-a (A–C) and
IL-12p40 (D–F) levels were measured in serum (A and D) and lysates of spleen (B and E) and liver (C and F) on day 1.5 p.i.
Data are from one of two individual experiments with similar results. n = 3–5 mice/group ± SD; NS, not significant; ***p < 0.001, **p < 0.01, *p < 0.05; one-way
ANOVA with Tukey post test.1996b). Splenic pDCs are themajor producers of IFN-I at day 1.5
p.i. (Asselin-Paturel et al., 2001; Dalod et al., 2002; Krug et al.,
2004; Scheu et al., 2008; Zucchini et al., 2008a), while IL-12
can be produced by various DC subsets (Alexandre et al.,
2014; Dalod et al., 2002). To better define the contribution of
cDCs and pDCs for NK cell activation, we next evaluated IL-
12p40 and IFN-a concentrations upon infection. Complete or
CD11c-specific deletion of TLR9/MyD88 signaling leads to signif-
icantly reduced IFN-a levels in the serum and spleen (Figures 4A
and 4B) compared to infected controls, whereas IL-12p40 pro-
duction is modestly reduced (Figures 4D and 4E). Consistent
with the viral load (Figure 1), production of proinflammatory cyto-
kines in the liver isMyD88dependent but TLR9 independent (Fig-
ures 4C and 4F). In turn, reactivation of MyD88 in CD11c+ cells
strongly restores IFN-a and IL-12p40 production in the serum(Figures 4A and4D), spleen (Figures 4Band 4E), and liver (Figures
4C and 4F). IFN-a levels, but not IL-12p40 levels, also increased
significantly in the serum and liver of pDC-MyD88ON mice
compared to MyD88OFF mice; however, the increase was not as
pronounced as that observed in DC-MyD88ON mice, in which
MyD88 is reactivated in both cDCs and pDCs (Figures 4A–4F)
and is likely more efficiently in pDCs from DC-MyD88ON mice
than is the case for pDC-MyD88ON mice.
NK Cell Effector Function Is Primarily Regulated by DC-
DerivedCytokines in a TLR9/MyD88-DependentManner
NK cells have been shown to directly senseMCMV-infected cells
via MyD88 (Cocita et al., 2015). In DC-MyD88ON mice, we
observe an intermediate reactivation of MyD88 in NK cells (Fig-
ure S6). Hence, to rule out the direct activation of NK cells byCell Reports 17, 1113–1127, October 18, 2016 1119
Figure 5. NK Cell Effector Function Is Primarily Regulated by DC-Derived Cytokines in a TLR9/MyD88-Dependent Manner
Sorted NK cells from WT, TLR9/, and MyD88OFF mice were cultured in vitro with or without DCs and infected with MCMV (MOI 2) for 24 hrs.
(A and B) Intracellular IFN-g expression in NK cells is shown in (A) as representative flow cytometric plots and in (B) as the frequency of IFN-g+ NK cells.
(legend continued on next page)
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MCMV in our experimental setting, we co-culturedWT, TLR9/,
and MyD88OFF NK cells with MCMV alone or with cDCs and
determined NK cell IFN-g production. In the absence of cDCs,
NK cells in all groups fail to produce IFN-g by direct sensing of
MCMV (Figure 5A). However, addition of WT cDCs to the culture
significantly enhanced IFN-g production in WT and TLR9/ and
to a lesser extent in MyD88OFF NK cells (Figures 5A and 5B). The
latter can be explained by previous reports showing that during
MCMV infection, the cytokines IL-18 and IL-33 activate NK cells
via MyD88 (Madera and Sun, 2015; Nabekura et al., 2015). Like-
wise, MyD88-deficient NK cells were demonstrated to have a
reduced ability to induce IFN-g production, whereas no effect
on NK cell degranulation was observed (Cocita et al., 2015; Ma-
dera and Sun, 2015; Nabekura et al., 2015).
Supporting the importance of DC-derived cytokines, the addi-
tion of exogenous IL-12 boosts NK cell IFN-g production while
IL-15 shows only a minor effect (Figures 5C and 5D). The reverse
is seen for NK cell degranulation, in which IL-15 is significantly
more potent than IL-12 (Figure 5E). This IL-15-mediated effect
is dose dependent (Figure 5F). To further evaluate the contribu-
tion of cDC- versus pDC-derived IL-15 to NK cell degranulation,
we sorted fms-like tyrosine kinase 3 ligand (Flt3-L)-differentiated
pDCs and cDCs and infected themwithMCMV for 24 hrs in vitro.
NK cells were then cultured in the presence of conditioned su-
pernatant from infected cDCs or pDCs with or without neutral-
izing antibody against IL-15. Both cDC and pDC supernatants
increased the percentage of CD107a+ NK cells to a similar
extent, but IL-15 neutralization prevented only cDC-mediated
NK cell degranulation (Figure 5G). Consistently, addition of
anti-IL-15 to MCMV-infected cDC-NK cell co-cultures damp-
ened NK cell degranulation (Figure 5H). To examine whether
in vivo IL-15 was also cDC derived, we infected WT mice with
MCMV for 1.5 days and sorted splenic pDCs and cDCs for RT-
PCR analysis. Our results confirm that upon in vivo infection,
cDCs are the predominant source of IL-12p40 and IL-15, while
IFN-b is primarily produced by pDCs (Figures 5I–5K) in accor-
dance with earlier studies (Nguyen et al., 2002; Zucchini et al.,
2008a). Altogether, our results show that CD11c+ DCs are
required for cytokine-driven activation of NK cells and cDC-
derived IL-12p40 and IL-15 regulate independent arms of NK
cell function during MCMV infection.
TLR9 andMyD88 Signaling in cDCs Promotes Robust NK
Cell Activation and Efficient Viral Clearance
In ItgaxCre+/TLR9fl/fl and DC-MyD88ON mice, both cDCs and
pDCs are targeted (Caton et al., 2007). Hence, our results ob-
tained thus far provide a holistic view on the TLR9/MyD88
signaling events derived frombothDCsubsets. To study the rele-
vance of TLR9 andMyD88 signaling in individual DC subsets dur-(C–E) WT NK cells were cultured with recombinant IL-12 or IL-15 in vitro. Represe
Representative histograms of CD107a expression on NK cells.
(F) Frequencies of CD107a+ NK cells cultured with different concentrations of re
(G) Sorted WT pDCs and cDCs were infected with MCMV for 24 hrs. WT NK cell
24 hrs in the presence or absence of anti IL-15 antibody. Degranulation was det
(H) Representative dot plots of WT NK cell degranulation after co-culture with cD
(I–K) Relative expression of IL-12 (I), IL-15 (J), and IFN-b (K) mRNAs in ex vivo sp
Data are from one of two individual experiments with similar results. NS, not signifiing MCMV infection, we adopted the ItgaxCre-iDTR (induced
diphtheria toxin receptor) mouse model, in which CD11c+ cells
can bedepleted by administeringDT (Buch et al., 2005). Because
pDCs express intermediate levels of CD11c (Arnold-Schrauf
et al., 2015), we first checked the depletion efficiency of both
DC subsets in vivo. Before infection, one round of DT efficiently
depleted cDCs and pDCs (Figure S7A). Furthermore, given that
NK cells can also express CD11c, ItgaxCre mice were crossed
to floxed red fluorescent protein (RFP) reporter mice (termed
ItgaxCre+/RFP+) (Luche et al., 2007), thereby terminally labeling
all CD11c+ cells. Immunostainings of spleen sections and flow
cytometry analysis confirmed a minor fraction of RFP+ NK cells
(Figure S7B). However, DT treatment of ItgaxCre-iDTR mice
affected neither the total number nor the activation status of NK
cells significantly (Figures S7C and S7D). Having thus excluded
a major effect on NK cells, we analyzed the contribution of
TLR9 andMyD88 signaling in individual DC subsets in regulating
NK cell function and MCMV clearance. This was achieved by
depleting the endogenous pool of CD11c+ cells in ItgaxCre-
iDTR mice and reconstituting them with Flt3-L-derived cDCs or
pDCs from WT, TLR9/, and MyD88OFF mice or both DC
subsets fromWTmice (termed mixed WT DCs), as shown in Fig-
ure 6A. As additional controls, we included DT-treated ItgaxCre-
iDTR mice that were either transgenic (DT sensitive) or WT (DT
insensitive) forCre expressionbutdid not receive anyDCs.Adop-
tive transfer ofWT cDCs or pDCs led to a pronounced increase in
NK cell CD69 expression compared to mice that did not receive
any DCs (Figure 6B). In contrast, WT cDCs were more effective
at inducing IFN-g production by NK cells than WT pDCs (Fig-
ure 6C). Simultaneously, TLR9/ and MyD88OFF cDCs pro-
moted significantly less NK cell CD69 expression and IFN-g
production compared to WT cDCs, whereas pDC contribution
to NK cell activation was less dependent on TLR9 signaling (Fig-
ures 6B and 6C). Besides, absence of CD11c+ DCs strongly
reducedNKcell degranulation (Figure 6D), but this was efficiently
restored by adoptive transfer of cDCs, pDCs, or a mix of both,
irrespective of their expression of TLR9 and MyD88 (Figure 6D).
Given that NK cells control clearance of MCMV in vivo, we
finally compared the contribution of eachDCsubset to viral clear-
ance. To address this aim,we infectedmicewithMCMVexpress-
ing luciferase and quantified viral load using intravital imaging.
Mice receiving mixed WT DCs were better at controlling MCMV
infection than mice that did not receive any DCs or mixed Toll-
like receptor (TLR) signaling-deficient DCs (Figure 6E). Further-
more, adoptive transfer of WT cDCs alone, but not pDCs, into
DC-depleted mice restored MCMV control (Figures 6F and 6G).
Again, transfer of TLR9/ or MyD88OFF DC subsets failed to
improve MCMV clearance at day 1.5 p.i. (Figures 6E and 6G).
Thus, we demonstrate that in the absence of pDCs, cDCs arentative dot plots (C) and quantification (D) of frequencies of IFN-g+ NK cells. (E)
combinant IL-15 (1, 10, or 100 ng/mL).
s were cultured with supernatants of these MCMV-infected cDCs or pDCs for
ermined as the frequency of CD107a+ NK cells in the culture.
Cs alone or with anti-IL-15 antibody.
lenic pDCs and cDCs sorted on day 1.5 of MCMV infection.
cant; ***p < 0.001, **p < 0.01, *p < 0.05; one-way ANOVA with Tukey post test.
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Figure 6. cDC-Derived TLR9 and MyD88 Signaling Promotes Robust NK Cell Effector Function and Efficient Viral Clearance
ItgaxCre-iDTR mice were used to evaluate the contribution of individual DC subsets in NK cell effector function and viral clearance. ItgaxCre-iDTR transgenic
mice are denoted as Tg (iDTR), and WT littermate controls are denoted as WT (iDTR).
(A) Schematic overview of DC depletion strategy by DT administration followed by adoptive transfer of sorted cDCs, pDCs, or mixed DCs in DC-depleted mice
later infected with 5 3 105 PFUs of MCMV.
(legend continued on next page)
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able to promote efficient NK cell activation and IFN-g production
in a TLR9- and MyD88-dependent manner, while both DC sub-
sets combine to achievemaximumclearance ofMCMV infection.
DISCUSSION
TLR9 and MyD88 are of central importance to fight MCMV,
because constitutive KO mice of either gene result in dramati-
cally reduced immune protection against the virus (Delale
et al., 2005; Krug et al., 2004; Tabeta et al., 2004; Zucchini
et al., 2008b). These signaling pathways are found, in addition
to pDCs, in a diverse range of other cell types. These include
cells that are permissive for MCMV replication, such as non-he-
matopoietic stromal cells (Benedict et al., 2006; Hsu et al., 2009),
which contain the bulk of viral infection after 3 days (Benedict
et al., 2006), and to a minor extent cDCs (Dalod et al., 2003). Us-
ing BM chimeras and transgenic mice that allowed us to specif-
ically delete TLR9 or reactivate MyD88 function in a cell type-
specific manner, we show that activation of the TLR9/MyD88
signaling pathway in hematopoietic cells is sufficient to promote
early viral control in the spleen, while in the liver, viral clearance is
MyD88 dependent but TLR9 independent. In contrast, TLR9
signaling within the non-hematopoietic compartment did not
contribute to viral clearance at day 1.5 p.i. Our results further
demonstrate that within the hematopoietic compartment,
TLR9/MyD88 expression in CD11c+ DCs, but not in LysM+ mac-
rophages, is required to control MCMV infection and to sustain
systemic IL-12p40 and IFN-I production.
Sensing of MCMV by DCs is vital for protective immunity,
mainly due to their cross-talk with NK cells (Degli-Esposti and
Smyth, 2005). For example, in mice with reduced DC numbers,
anti-viral NK cell function in the spleen has been shown to be
compromised (Andoniou et al., 2005; Andrews et al., 2003;
Mitrovic et al., 2012; Robbins et al., 2007). NK cells confer immu-
nity against MCMV through the production of inflammatory cyto-
kines such as IFN-g and by direct killing of infected cells (Bukow-
ski et al., 1984). Here we show that at day 1.5 p.i., TLR9 and
MyD88 signaling in CD11c+ DCs is required for NK cell contrac-
tion, CD69 expression, and IFN-g production, suggesting an
essential role for these pathways in coordinating ensuing im-
mune responses against MCMV.
Early DC-NK cell interaction is regulated by various pro-inflam-
matory cytokines. Among them, IL-12 has been shown to elevate
IFN-g secretion by NK cells, while IFN-I and IL-15 have been
described to trigger NK cell cytotoxicity, proliferation, and sur-
vival (Baranek et al., 2012; Nguyen et al., 2002;Orange andBiron,
1996b). The first short-lived peak of IFN-I production after sys-
temic MCMV infection at 8 hr p.i. is mainly stromal cell derived
(Schneider et al., 2008), while the second, more sustained peak
from day 1.5 p.i. is pDC dependent (Dalod et al., 2002). Consis-
tent with this, in our study, reactivation ofMyD88 signaling exclu-
sively in pDCs significantly restores IFN-I levels at day 1.5 p.i.(B–D) MFI of CD69 expression (B), percentage of IFN-g+ (C), and percentage of
(E–G) Mice were infected with MCMV-luciferase at 53 105 PFUs, and viral clearan
sorted pDCs (F), and sorted cDCs (G).
Data are from one of three individual experiments with similar results. n = 3–5mice
way ANOVA with Tukey post test.compared to MyD88OFF mice. However, MyD88 signaling only
inpDCshasanegligible impact onNKcell functionandviral clear-
ance. In accordance, previous reports using experimental abla-
tion of pDCs in vivo suggest that this DC subset is dispensable
for NKcell activation (Dalod et al., 2002; Krug et al., 2004; Swiecki
et al., 2010). Although in our experimental settings only a fraction
of pDCs reactivates MyD88 (approximately 30%), our results us-
ing reconstitution of specific DC populations upon total DC abla-
tion in ItgaxCre-iDTR mice further support the notion that pDCs
alone may not be sufficient for anti-MCMV immunity. Moreover,
although NK cell cytotoxicity was thought to be strongly influ-
enced by IFN-b induced after infection (Steinberg et al., 2009),
our results suggest that loss of IFN-a and IFN-b in IRF7/IFN-
bD/D mice or complete loss of IFN-I signaling in IFNAR-1/
mice has no influence on NK cell degranulation and cytotoxicity.
Altogether, these data suggest that alternative signals, other than
pDC-derived IFN-I, may promote effector NK cell cytotoxic activ-
ity in TLR9/MyD88-deficient mice.
Previous studies alluded to an important role for cDCs in pro-
moting NK cell activation and/or virus control during MCMV
infection (Andoniou et al., 2005; Andrews et al., 2003; Asselin-
Paturel et al., 2001; Baranek et al., 2012; Delale et al., 2005;
Swiecki et al., 2010; Zucchini et al., 2008a). However, we demon-
strate that TLR9 andMyD88mechanisms in cDCs alone are able
to intercede in the absence of pDCs to promote robust NK cell
function and viral clearance in infected mice. This finding can
be understood in light of a previous report showing that pDC-
derived IFN-I impairs IL-12 production by splenic cDCs in a
signal transducer and activator of transcription 1 (STAT-1)-
dependentmanner (Dalod et al., 2002). Therefore, in the absence
of IFN-I from pDCs, an over-production of IL-12 by cDCs (Dalod
et al., 2002; Krug et al., 2004; Swiecki et al., 2010) may efficiently
generate effector NK cell function. We found that IL-12 alone,
which is mainly derived from cDCs, can robustly induce IFN-g
secretion from NK cells.
Consistent with previous studies (Cocita et al., 2015; Madera
and Sun, 2015; Nabekura et al., 2015), we propose that MyD88
expression in NK cells is required exclusively to transduce DC-
derived IL-1 family cytokine signals, because induction of IFN-g
production in MyD88-deficient NK cells induced by MCMV-in-
fected WT DCs was reduced compared to WT or TLR9-deficient
NK cells. Besides the effects of IL-12 on NK cell activation, cDC-
derived IL-15 strongly boosts NK cell degranulation. Altogether,
our data indicate that the presence of TLR9 andMyD88 signaling
in cDCs allows adequate NK cell function and early MCMV clear-
ance. In this respect, our study introduces an interesting concept,
because it is generally assumed that duringmany viral infections,
including MCMV infection, the primary function of TLR9 and
MyD88 signaling is to promote high systemic levels of IFN-I by
pDCs, with a lesser, if any, role in the direct activation of cDCs.
We also demonstrate that cDC-derived TLR9 and MyD88
signaling affects only the early cytokine-dependent NK cellCD107a+ splenic NK cells (D) at day 1.5 p.i.
ce was evaluated by intravital imaging after adoptive transfer of mixed DCs (E),
/group; means ± SD; NS, not significant; ***p < 0.001, **p < 0.01, *p < 0.05; one-
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activation at day 1.5 p.i., while the expansion of Ly49H+ NK cells
at day 8 p.i. remains unchanged. This correlates with previous re-
ports in which Ly49H+ NK cells from BALB/c-Ly49H+MyD88/
mice display minimal changes in expansion and activation
compared to NK cells from BALB/c-Ly49H+ mice at days 3 and
6 p.i. (Cocita et al., 2015). Similarly, Geurs et al. (2009) showed
that the engagement of Ly49H receptor in C57BL/6 mice was
able to compensate for the loss of early cytokine stimulation,
and by day 3 p.i., Ly49H+ NK cells expanded comparably to
WT mice in the absence of IFN-I.
In summary, by generating valuable genetic tools, we were
able to reconstruct the chain of events occurring early upon sys-
temicMCMV infection.We show thatMCMVclearance is depen-
dent on TLR9 and MyD88 signaling from hematopoietic cells.
CD11c+ cDCs are fundamental in initiating protective immunity
against MCMV, and in the absence of cDCs, MCMV clearance
and NK cell function are significantly impaired. Specifically,
cDCs control independent arms of NK cell function during acute
MCMV infection by driving NK cell IFN-g and acquisition of cyto-
toxic granules via IL-12 and IL-15, respectively. Our data explain
mechanistically why depletion of CD11c+ DCs significantly in-
creases the viral load in primary organs, as recently demon-
strated (Holzki et al., 2015). Altogether, our results show that in
the absence of pDCs, TLR9 and MyD88 signaling in cDCs is
mandatory for MCMV clearance and NK cell effector function
during the early phase of MCMV infection. Overall, our data pro-
vide a paradigm shift in understanding the importance of cDCs in
early MCMV immunity by demonstrating that direct activation of
cDCs via TLR9 and MyD88 is sufficient to ensure adequate anti-
viral immune responses after acute MCMV infection.EXPERIMENTAL PROCEDURES
Ethics Statement
All animal experiments were performed as per the German animal protection
law (TierSchG BGBl. I S. 1105; 25.05.1998). The housing and handling of
mice was set by the regulations of the Federation of European of Laboratory
Animal Science Associations (FELASA) and the national animal welfare body
of the Gesellschaft f€ur Versuchstierkunde/Society of Laboratory Animal Sci-
ence (GV-SOLAS). All animal experiments were approved by the Lower Sax-
ony Committee on the Ethics of Animal Experiments, as well as the responsible
state office (Lower Saxony State Office of Consumer Protection and Food
Safety), under permits 33.9-42502-04-12/1020 and 33.9-42502-04-09/1785.
Surgery of mice was performed following euthanasia in a CO2 chamber in
accordance to the German animal welfare law. All efforts were made to mini-
mize suffering.Mice
All mouse lines were bred at the animal facility of Twincore (Hannover,
Germany) or at the Helmholtz Centre for Infection Research (HZI, Braunsch-
weig, Germany) under specific pathogen-free conditions. Mice between 6
and 12 weeks of age were used for experiments. Among the mouse lines
used in our study, TLR9/ mice were provided by Shizuo Akira (Hemmi
et al., 2000), MyD88OFF mice were provided by Bernard Holzmann (Gais
et al., 2012), RFP mice were provided by Hans Jo¨rg Fehling (Luche et al.,
2007), ItgaxCre mice were provided by Boris Reizis (Caton et al., 2007), LysM-
Cremicewere provided by Irmgard Fo¨rster (Clausen et al., 1999), IRF7/mice
were provided by Tadatsugu Taniguchi (Honda et al., 2005), IFN-bWT/D mice
were provided by S.L. (Lienenklaus et al., 2009), iDTR mice were provided by
Ari Waisman (Buch et al., 2005), and IFNAR-1/ mice were provided by Till
Strowig (M€uller et al., 1994). All mice were raised on a C57BL/6J background.1124 Cell Reports 17, 1113–1127, October 18, 2016Generation of TLR9fl/fl Mice
Exon 2, comprising the major coding sequence of the Tlr9 gene, was flanked
by loxP sites to generate TLR9fl/fl mice. The targeting vector consisted of a
loxP site downstream of exon 1 followed by a FRT-flanked neomycin resis-
tance gene upstream of exon 2. An additional F3-flanked puromycin resis-
tance cassette was inserted following exon 2 to increase co-recombination
frequency of both loxP sites. The targeting vector was also composed of an
ampicillin resistance gene and herpes simplex virus thymidine kinase (Tk)
gene driven by a phosphoglycerate kinase (pgk) promoter. The targeting vec-
tor was linearized with Not I and transfected into C57BL/6N embryonic stem
cells (ESCs) by electroporation. G418 and ganciclovir-resistant ESCs were
selected as correctly targeted colonies and underwent Southern blot analysis.
The TLR9fl/fl mice were next backcrossed with C57BL/6J mice for at least ten
generations before being used in experiments. TLR9fl/fl mice were then
crossed to cell-specific Cre recombinase-expressing mouse lines to allow
Cre-mediated deletion of exon 2 and subsequent removal of most of the
open reading frame of the Tlr9 gene (Figure S1A). Hence, using this approach,
mice with cell-specific loss of TLR9 function in Cre recombinase-expressing
cells were obtained. The TLR9fl/fl mice were generated by Taconic Artemis
as part of a collaboration initiated by H.W. and T.S.
Generation of BM Chimeric Mice
BM chimeric mice were generated as previously described (Dudek et al.,
2016).
MCMV Viral Strains
bacterial artificial chromosome (BAC)-derived MCMV (Jordan et al., 2011) and
luciferase-expressing MCMV strains were provided by L.C.-S. and used for
infection experiments. Propagation of MCMV stocks was carried out as previ-
ously described (Lindenberg et al., 2014).
Generation of MCMV-Die2-luc
For the generation of MCMV-luciferase, the firefly luciferase cassette of the
pGL3 plasmid (Promega) was inserted into the pcDNA3.1 plasmid (Life Tech-
nologies) using the restriction enzymes HindIII and XbaI, thereby adding the
bovine growth hormone (BGH) poly(A) region to the luciferase cassette. In
the following step, the ie2 gene of the MCMV BAC (Smith strain, repaired
MCK-2) (Jordan et al., 2011) was replaced with the luciferase-BGH poly(A)
cassette via en passant mutagenesis (Tischer et al., 2010). The start codon
of the luciferase gene is in the exact position of the start codon of the ie2
gene, creating an MCMV virus lacking the ie2 gene with luciferase driven by
the major immediate early promoter (MIEP).
In Vivo Systemic Infection
Mice were either infected intraperitoneally (i.p.) with 5 3 105 plaque-forming
units (PFUs) of the MCMV-Smith strain, MCMV-luciferase, or were mock-
infected with PBS. For MCMV-luciferase-infected mice, images were quanti-
fied at days 1.5, 3, 6, and 8 p.i. For NK cell analysis, spleens were harvested
at days 1.5 and 8 p.i., and virus concentration was determined in the spleen
and liver at day 1.5 p.i.
MCMV Quantification by Plaque Assay
Spleen and liver were harvested from day 1.5 p.i. mice and collected in 0.5 mL
DMEM. Virus titers in the infected organs were quantified as described previ-
ously (Lindenberg et al., 2014).
In Vitro MCMV Spin Infection
Flow cytometry-sorted Flt3-L-derived pDCs and cDCs were seeded at 13 105
cells/well in a 96-well U-bottom plate. DCs were treated with MCMV (MOI 2),
1 mM CpG, or PBS for 24 hrs. DC infection was performed by centrifugation
at 1,500 rpm for 30 min at 37C and later incubated at 37C, 5% CO2, for
24 hrs.
Generation of Flt3-L-Differentiated BM DCs
Tibiae and femurs from mice were harvested, and BM was isolated. BM
DCs comprising pDCs and cDCs were generated by in vitro differentiation
with Flt3-L as previously described (Naik et al., 2010).
Flow Cytometry
Cells were washed in PBS and stainedwith the live/dead fixable aqua dead cell
stain kit (Invitrogen) to exclude dead cells. Cells were further processed for
staining as previously described (Puttur et al., 2013).
Antibodies
In this study,all antibodies usedwerepurchased fromeBioscienceunless stated
otherwise. The following fluorochrome-labeled anti-mouse antibodies were
used. For DCs after in vitro infection, B220 (RA3-6B2), CD11c (N418), CD86
(GL1), MHCII (AF6-120.1), and CD8a (53–6.7) were used. For splenic NK cells,
NK 1.1 (PK136), Ly49H (3D10), CD69 (H1.2F3), CD3ε (145-2C11), and CD107a
(eBio1D4B) antibodies were stained extracellularly. IFN-g (XMG1.2) staining
wasperformedby intracellular staining.For IL-15neutralization,goat anti-mouse
IL-15 antigen affinity-purified polyclonal antibody from R&D Systemswas used.
Cell Sorting
Cell sorting was carried out at the Cell Sorting Core facility of the Hannover
Medical School using the FACSAria (BD Biosciences), XDP or MoFlo (Beck-
man Coulter) fluorescence-activated cell sorting (FACS) machines. In vitro
differentiated or ex vivo pDCs were sorted as CD11cintB220+, cDCs were
sorted as CD11chiB220, and NK cells were sorted as NK1.1+CD3 from
spleens. Cells were processed as previously described (Puttur et al., 2013).
Isolation of Splenic NK Cells
Spleenswerecut into smallpiecesandmechanicallyhomogenized inRPMI1640
Glutamaxmedium (Gibco) supplemented with 10% fetal calf serum (FCS), 5 mM
b-mercaptoethanol (Gibco), and 100 U/mL penicillin/streptomycin (Biochrom).
A single-cell suspension was prepared, and red blood cells (RBCs) were lyzed
in RBC lysis buffer (150mMNH4Cl, 10mMKHCO3, and 0.1mMEDTA). The iso-
latedcellswerecountedby trypanbluedeadcell exclusionmethod,and livecells
were adjusted to the same cell number for flow cytometry staining.
In Vitro NK Cell Stimulation
Sorted NK cells were stimulated for 24 hrs in the presence of cDCs and/or
pDCs at 1:1 ratio, recombinant murine IL-12 (100 ng/mL) from PeproTech,
recombinant murine IL-15 (1, 10, or 100 ng/mL) from PeproTech, 1 mM CpG,
or MCMV (MOI 2). In the last 6 hr, IL-2 (800 U/mL) and brefeldin A (3 mg/mL)
were added; later, the cells were stained for intracellular IFN-g.
NK Cell Degranulation Assay
Ex vivo isolated and sorted day 1.5 MCMV-infected splenic NK effector (E)
cells were cultured in the presence of YAC-1 target (T) cells. YAC-1 cells
were provided by R.J. NK cells at a concentration of 1 3 105 cells/well and
were co-cultivated with YAC-1 cells at E:T ratios of 5:1, 2.5:1, and 1:1 in a
96-well V-bottom plate in the presence of anti-CD107a (eBio1D4B) antibody
at a final concentration of 0.01 mg/mL at 37C, 5% CO2. Following 1 hr of in-
cubation, monensin (BD Biosciences) was added to inhibit endosomal acidifi-
cation at a final concentration of 5mg/mL, and incubationwas continued for an
additional 3 hr as described previously (Marquardt et al., 2010). After a 4 hr in-
cubation period, cells were stained and analyzed by flow cytometry.
NK Cell Chromium Release Assay
Splenic NK cells were sorted on day 1.5 p.i. and pre-activatedwith IL-2 for 2 hr.
Activated NK cells were then co-cultured with YAC-1 target cells that were
labeled with 1 mCi/mL 51Cr for 2 hr at an E:T ratios of 5:1 and 2.5:1 in a 96-
well V-bottom plate. Effector and target cells were co-cultured at 37C for
4 hr, and Cr-release assay was performed by the R.J. lab as described earlier
(Jacobs et al., 1992).
Cytokine Quantification
Supernatants from in vitro-stimulated sorted cDCs, pDCs, or serum and organ
homogenate samples from MCMV-infected mice were used to determine
cytokine concentration by ELISA as previously described (Puttur et al., 2013).
Immunofluorescence
Cryo sections (5 mm) of snap-frozen lung tissue were fixed before incubation
with anti-NKp46 (R&D Systems). After serum block (Dianova), sections wereincubated with Alexa 488-labeled anti-goat (Invitrogen) followed by incubation
with anti-RFP (Antibodies Online). RFP antibody was detected by Alexa 555-
labeled anti-rabbit (Invitrogen), and nuclei were stained using DAPI (Sigma).
Sections were placed on coverslips with Fluoromount G (eBioscience), and
images were acquired using the AxioImager Z1 microscope (Carl Zeiss). All
evaluations were performed in a blinded manner.
In Vivo Imaging
Mice infected with MCMV-luciferase were anesthetized in a chamber supplied
with isoflurane 2% O2. IVIS Spectrum computed tomography (CT) (Perki-
nElmer) was used for imaging, and further analysis was performed using Living
Image v.4.3.1 software (PerkinElmer). Luciferin was administered i.p. in 100 mL,
2 min before analysis. Mice were placed in an imaging platform, and whole-
body images were taken at a binning factor of 8 over 5 s to 1 min at the indi-
cated time points during infection. Luminescence emitted from the region of
interest in each mouse was quantified as total flux and pseudo-color images
representing intensity from virus-derived luminescence were generated. For
detection of three-dimensional bioluminescent signals, anesthetized mice
were first scanned by CT under the mode of medium resolution and then
MCMV-derived bioluminescent signals were excited under the wavelength
firefly 612 nm and imaged at a binning factor of 8 over 5 s to 1 min.
RNA Isolation and Real-Time qPCR
RNA from spleens and FACS-sorted pDCs and cDCs were isolated as per in-
structions using the RNeasyMicro Kit (QIAGEN). Cells were lyzed in RLT buffer
with 0.01% b-mercapthanol. The cell lysate was placed in MinElute spin col-
umns with 70% ethanol. The samples were treated with DNase for 15 min
and inactivated with RW1 buffer. After washing, purified RNA was eluted in
14 mL of RNase-free water.
The following primers were used: b-actin forward strand 50-TGTTACCA
ACTGGGACGACA-30, reverse strand 50-GGGGTGTTGAAGGTCTCAAA-30;
TLR9 forward strand 50-CCAGACGCTCTTCGAGAACC-30; reverse strand 50-
GTTATAGAAGTGGCGGTTGT-30; and Myd88 forward strand 50-AGAGCTG
CTGGCCTTGTTAG-30, reverse strand 50-TTCTCGGACTCCTGGTTCTG-30.
Primers were obtained from Eurofins MWG Operon and were analyzed on
a LightCycler 480 II (Roche). Relative gene expression was calculated as
[2Ct(target)/2Ct(b-Actin)].
Statistics
The unpaired Student’s t test, one-way ANOVA, and the Kruskal-Wallis
test were used to calculate the statistically significant differences between
samples. A value for p < 0.05 was considered significant, as indicated by an
asterisk sign: *p < 0.05, **p < 0.01, and ***p < 0.001.
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